• Cite/Export
  Cite/Export

  Copy a citation

  APA (6th ed.)

  

  Chicago (Author-Date, 15th ed.)

  

  Harvard (18th ed.)

  

  MLA (7th ed.)

  

  Turabian (6th ed.)

  

  Export a citation

  Export to RefWorks   Export to EndNote / Reference Manager   Export to EasyBib
  Export to EndNote / Reference Manager(non-Latin)   Cancel

  Note: Citations are based on reference standards. However, formatting rules can vary widely between applications and fields of interest or study. The specific requirements or preferences of your reviewing publisher, classroom teacher, institution or organization should be applied.
• Print
• E-mail
  E-mail

  All fields are required.

  The E-mail Address(es) field is required. Please enter recipient e-mail address(es).

  The E-mail Address(es) you entered is(are) not in a valid format. Please re-enter recipient e-mail address(es).

  You may send this item to up to five recipients.

  Enter recipient e-mail address(es): Separate up to five addresses with commas (,)

  The name field is required. Please enter your name.

  Enter your name: The subject field is required. Please enter the subject. Subject:

  The E-mail message field is required. Please enter the message.

  E-mail Message: I thought you might be interested in this item at http://www.worldcat.org/oclc/830009056 Title: Ciprofloxacin or doxycycline for the treatment of anthrax : a review of the clinical and cost-effectiveness Publisher: [Ottawa, Ont.] : Canadian Agency for Drugs and Technologies in Health, 2012 OCLC:830009056

  
  

  Please verify that you are not a robot.

  Cancel
• Share
• Permalink
  Permalink

  Copy this URL to link to this page:

• Write a review
• Rate this item:
• • 1
  • 2
  • 3
  • 4
  • 5

Ciprofloxacin or doxycycline for the treatment of anthrax : a review of the clinical and cost-effectiveness

Author:	Canadian Agency for Drugs and Technologies in Health.
Publisher:	[Ottawa, Ont.] : Canadian Agency for Drugs and Technologies in Health, 2012
Series:	Rapid response report.
Edition/Format:	eBook : Document : EnglishView all editions and formats
Summary:	The potential use of anthrax as a biological terrorist attack has prompted health authorities to investigate different treatment protocols and discuss which antibiotic agent should be used in the event of an attack. Ciprofloxacin, and doxycycline were the primary agents used after the 2001 attack in the US, and amoxicillin was reserved for pregnant or breast feeding women, children, and those with adverse effects associated with ciprofloxacin or doxycycline. Re-evaluation of these agents is required over time considering changes in resistance patterns, costs, or other factors. This report will review the clinical and cost-effectiveness literature of ciprofloxacin and doxycycline for anthrax.  Read more...
Rating:	(not yet rated) 0 with reviews - Be the first.
Subjects	Anthrax -- Chemotherapy. Ciprofloxacin -- Therapeutic use. Anthrax -- drug therapy. View all subjects
More like this	Similar Items